Triangle Securities Wealth Management Lowers Position in iShares Biotechnology ETF (NASDAQ:IBB)

Triangle Securities Wealth Management lessened its stake in iShares Biotechnology ETF (NASDAQ:IBB) by 4.4% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 3,196 shares of the financial services provider’s stock after selling 148 shares during the period. Triangle Securities Wealth Management’s holdings in iShares Biotechnology ETF were worth $423,000 at the end of the most recent quarter.

Several other hedge funds have also bought and sold shares of the stock. Darwin Wealth Management LLC purchased a new position in shares of iShares Biotechnology ETF during the 3rd quarter valued at approximately $29,000. Highline Wealth Partners LLC purchased a new position in shares of iShares Biotechnology ETF during the 3rd quarter valued at approximately $30,000. Ashton Thomas Securities LLC purchased a new position in shares of iShares Biotechnology ETF during the 3rd quarter valued at approximately $36,000. Modus Advisors LLC purchased a new position in shares of iShares Biotechnology ETF during the 4th quarter valued at approximately $41,000. Finally, Voisard Asset Management Group Inc. purchased a new position in shares of iShares Biotechnology ETF during the 3rd quarter valued at approximately $59,000. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Trading Down 0.2 %

Shares of NASDAQ:IBB opened at $132.65 on Monday. iShares Biotechnology ETF has a 1 year low of $123.60 and a 1 year high of $150.57. The business’s 50 day moving average price is $136.62 and its 200-day moving average price is $141.86.

iShares Biotechnology ETF Cuts Dividend

The company also recently disclosed a dividend, which was paid on Friday, December 20th. Shareholders of record on Tuesday, December 17th were issued a $0.0624 dividend. The ex-dividend date was Tuesday, December 17th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.